The bioinformatics analysis of quercetin in octagonal lotus for the screening of breast cancer MYC, CXCL10, CXCL11, and E2F1

1. Abolghasemi, M, Tehrani, SS, Yousefi, T, et al. (2020) MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. Journal of Cellular Physiology 235: 5008–5029.
Google Scholar | Crossref | Medline2. Abolghasemi, M, Tehrani, SS, Yousefi, T, et al. (2020) Critical roles of long noncoding RNAs in breast cancer. Journal of Cellular Physiology 235: 5059–5071.
Google Scholar | Crossref | Medline3. Fan, L, Strasser-Weippl, K, Li, J-J, et al. (2014) Breast cancer in China. The Lancet Oncology 15(7): e279–e289.
Google Scholar | Crossref | Medline4. Sun, Y-S, Zhao, Z, Yang, Z-N, et al. (2017) Risk factors and preventions of breast cancer. International Journal of Biological Sciences 13(11): 1387–1397.
Google Scholar | Crossref | Medline5. Yuan, Y (2011) Study on the Extraction and Analysis of Podophyllotoxin and the New Method of Quality Control[D]. Changsha, China: Hunan University.
Google Scholar6. Lu, J (2009) The pharmacology and clinical application of Dysosma Versipellis[J]. Modern Medicine and Health (23): 3608–3609.
Google Scholar7. Mukherjee, A, Basu, S, Sarkar, N, et al. (2001) Advances in cancer therapy with plant based natural products. Current Medicinal Chemistry 8: 1467–1486.
Google Scholar | Crossref | Medline8. Mantle, D, Lennard, TW, Pickering, AT (2000) Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adverse drug reactions and toxicological reviews 19: 223–240.
Google Scholar | Medline9. Ezzati, M, Yousefi, B, Velaei, K, et al. (2020) A review on anti-cancer properties of Quercetin in breast cancer. Life Sciences 248: 117463.
Google Scholar | Crossref | Medline10. Kasiri, N, Rahmati, M, Ahmadi, L, et al. (2020) Therapeutic potential of Quercetin on human breast cancer in different dimensions. Inflammopharmacology 28(1): 39–62.
Google Scholar | Crossref | Medline11. Zhu, L, Xue, L (2019) Kaempferol suppresses proliferation and induces cell cycle arrest, apoptosis, and DNA damage in breast cancer cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27(6): 629–634.
Google Scholar | Crossref12. Awad, AB, Roy, R, Fink, CS (2003) Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncology reports 10(2): 497–500.
Google Scholar | Medline13. Awad, AB, Barta, SL, Fink, CS, et al. (2008) β-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Molecular Nutrition & Food Research 52(4): 419–426.
Google Scholar | Crossref | Medline14. Chua, LS A review on plant-based rutin extraction methods and its pharmacological activities. Journal of Ethnopharmacology. 2013;150(3):805-817.
Google Scholar | Crossref | Medline15. Dogra, A, Gour, A, Bhatt, S, et al. (2013) A review on plant-based rutin extraction methods and its pharmacological activities. Journal of Ethnopharmacology 150(3): 805–817.
Google Scholar | Crossref | Medline16. Elsayed, HE, Ebrahim, HY, Mohyeldin, MM, et al. (2017) Rutin as a novel c-met inhibitory lead for the control of triple negative breast malignancies. Nutrition and Cancer 69(8): 1256–1271.
Google Scholar | Crossref | Medline17. Novak, CM, Horst, EN, Taylor, CC, et al. (2019) Fluid shear stress stimulates breast cancer cells to display invasive and chemoresistant phenotypes while upregulating PLAU in a 3D bioreactor. Biotechnology and Bioengineering 116(11): 3084–3097.
Google Scholar | Crossref | Medline18. Wu, M-Y, Li, C-J, Hou, M-F, et al. (2017) New insights into the role of inflammation in the pathogenesis of atherosclerosis. International Journal of Molecular Sciences 18(10): 2034.
Google Scholar | Crossref19. Zhou, S, Jin, J, Wang, J, et al. (2021) Effects of breast cancer genes 1 and 2 on cardiovascular diseases. Current Problems in Cardiology 46(3): 100421.
Google Scholar | Crossref | Medline20. Sepahvand, P, Makvandi, M, Samarbafzadeh, A, et al. (2019) Human Cytomegalovirus DNA among Women with Breast Cancer. Asian Pacific Journal of Cancer Prevention 20(8): 2275–2279.
Google Scholar | Crossref | Medline21. Goodrum, F, Caviness, K, Zagallo, P (2012) Human cytomegalovirus persistence. Cellular Microbiology 14(5): 644–655.
Google Scholar | Crossref | Medline22. Gong, Y, Zhao, J, Wang, M (2016) Research progress on the relationship between human cytomegalovirus infection and breast cancer[J]. Microbes and Infection 11(01): 55–58.
Google Scholar23. Liu, Z, Jiang, L, Liang, G, et al. (2017) Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: a review and meta-analysis of prophylaxis management. Journal of Viral Hepatitis 24(7): 561–572.
Google Scholar | Crossref | Medline24. Wu, H, Zhao, C, Adhikari, VP, et al. (2017) The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China. Oncotarget 8(11): 18185–18190.
Google Scholar | Crossref | Medline25. Hu, N, Zhang, J, Cui, W, et al. (2011) miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. Journal of Biological Chemistry 286(15): 13714–13722.
Google Scholar | Crossref | Medline26. Ellis, H, Ma, CX (2019) PI3K inhibitors in breast cancer therapy. Current Oncology Reports 21(12): 110.
Google Scholar | Crossref | Medline27. Rahmani, F, Ferns, GA, Talebian, S, et al. (2020) Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer. Gene 737: 144459.
Google Scholar | Crossref | Medline28. Lourenco, C, Kalkat, M, Houlahan, KE, et al. (2019) Modelling the MYC-driven normal-to-tumour switch in breast cancer. Disease models & mechanisms 12(7): dmm038083.
Google Scholar | Crossref | Medline29. Liang, Z-R, Qu, L-H, Ma, L-M (2020) Differential impacts of charcoal-stripped fetal bovine serum on c-Myc among distinct subtypes of breast cancer cell lines. Biochemical and Biophysical Research Communications 526(1): 267–272.
Google Scholar | Crossref | Medline30. Tokunaga, R, Zhang, W, Naseem, M, et al. (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treatment Reviews 63: 40–47.
Google Scholar | Crossref | Medline31. Liu, L, Callahan, MK, Huang, D, et al. (2005) Chemokine receptor CXCR3: an unexpected enigma. Current Topics in Developmental Biology 68: 149–181.
Google Scholar | Crossref | Medline32. Ertosun, MG, Hapil, FZ, Osman Nidai, O (2016) E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine & Growth Factor Reviews 31: 17–25.
Google Scholar | Crossref | Medline33. Zheng, X, Huang, M, Xing, L, et al. (2020) The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Molecular Cancer 19(1): 73.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif